STOCK TITAN

February 2024 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of February 2024 Every stock ranked by its February 2024 gain, with or without news

100

Ranked gains

+1092.05%

Largest, HOLO

93.0%

Above baseline, day +5

5.0%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in February 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 HOLO +1092.05% against the close of 02/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MicroCloud Hologram Planned to Join the Communications Industry Association

05:20 ET premarket

2 BMR More than one ranked move this month 2+ ranked moves +371.56% against the close of 02/09/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Beamr and NVIDIA team up to accelerate adoption of the newest video standard - AV1

07:00 ET premarket

3 VANI +270.30% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

08:30 ET premarket

4 JANX +229.47% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors

16:05 ET after hours

5 SCTL +132.61% against the close of 02/28/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.

16:29 ET after hours

6 VKTX +121.02% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

07:03 ET premarket

7 ENGN +116.54% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution catalyst from a later release the same session enGene Announces Leadership Succession Plan

06:45 ET premarket

8 GLT +106.25% against the close of 02/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader

07:00 ET premarket

9 AKLI +104.11% against the close of 02/23/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan

08:47 ET premarket

10 NSTG Also on the opposite board this month on both boards +97.93% against the close of 02/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement NanoString Announces Completion of Financing to Support Restructuring Process

06:30 ET premarket

11 MNPR More than one ranked move this month 2+ ranked moves +96.49% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

07:00 ET premarket

12 GRRR +96.36% against the close of 02/02/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gorilla Technology Group Reports Results Through Third Quarter 2023

08:00 ET premarket

13 VTVT +95.88% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

08:00 ET premarket

14 MNPR More than one ranked move this month 2+ ranked moves +95.27% against the close of 02/16/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

08:00 ET premarket

15 FDMT +84.62% against the close of 02/02/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results 4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD

17:00 ET after hours

16 PLCE Also on the opposite board this month release reads negative on both boards +81.12% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads negative, stock rose 81.12% The Children’s Place Provides Shareholder Update

06:30 ET premarket

17 BOF More than one ranked move this month 2+ ranked moves +80.06% against the close of 02/09/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually

08:00 ET premarket

18 EBS +78.29% against the close of 02/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

07:00 ET premarket

19 TELO +69.76% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Telomir Pharmaceuticals Announces Closing of Initial Public Offering

16:05 ET after hours

20 AXTI +69.30% against the close of 02/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AXT, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

16:05 ET after hours

21 MRVI +63.60% against the close of 02/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

22 COGT +59.34% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

07:00 ET premarket

23 BZFD +58.10% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition BuzzFeed, Inc. Announces Sale of Complex to NTWRK in All-Cash Deal

16:05 ET after hours

24 FHTX +55.45% against the close of 02/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor

07:00 ET premarket

25 SOGP +53.74% against the close of 02/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sound Group Embraces Generative AI to Unveil New AI-Powered Applications

06:30 ET premarket

26 ROOT +53.29% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Root, Inc. Announces 2023 Fourth Quarter and Full Year Results

16:15 ET after hours

27 BAND +51.77% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Bandwidth Announces Fourth Quarter and Full Year 2023 Financial Results, Exceeding Revenue and Profitability Guidance

07:00 ET premarket

28 CNVS Also on the opposite board this month on both boards +51.61% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Cineverse Partners with Google Cloud to Launch a Conversational AI-Powered Search & Discovery Tool for Film and Television Content

09:00 ET premarket

29 ARM +47.89% against the close of 02/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arm Holdings plc Reports Results for the Third Quarter of the Financial Year Ending 2024

16:02 ET after hours

30 MIRA +45.99% against the close of 02/02/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MIRA Pharmaceuticals Provides Corporate Update

08:30 ET premarket

31 BLZE +45.15% against the close of 02/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

32 MATV +42.69% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Mativ Announces Fourth Quarter and Full Year 2023 Results

16:40 ET after hours

33 CRDL +42.31% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

07:27 ET premarket

34 ONMD +42.23% against the close of 02/28/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.

08:00 ET premarket

35 BMR More than one ranked move this month 2+ ranked moves +41.31% against the close of 02/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Beamr Imaging Ltd. Announces Pricing of $12 Million Public Offering

20:02 ET after hours

36 JMIA +41.18% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Jumia Reports Fourth Quarter and Full Year 2023 Results

08:00 ET premarket

37 KRYS +41.02% against the close of 02/23/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

08:00 ET premarket

38 ACMR +40.80% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results

05:00 ET premarket

39 SGMO +40.15% against the close of 02/09/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

08:05 ET premarket

40 LASE +39.42% against the close of 02/28/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Laser Photonics Scores Order from Pima Air & Space Museum for Its CleanTech Laser Cleaning System

07:00 ET premarket

41 WISH +39.11% against the close of 02/09/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition ContextLogic Announces Agreement to Sell Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10 for $173 Million in Cash

08:00 ET premarket

42 GTHX Also on the opposite board this month on both boards +38.75% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

06:30 ET premarket

43 VLCN +38.68% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Business Update from John Kim New CEO at Volcon Inc

07:30 ET premarket

44 DNLI +38.25% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Denali Therapeutics Announces $500 million Private Placement Equity Financing

08:00 ET premarket

45 LRMR +36.84% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Larimar Therapeutics Announces Proposed Underwritten Public Offering

16:18 ET after hours

46 CTMX +36.36% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement CytomX Therapeutics to Present at Upcoming March Investor Conferences

08:00 ET premarket

47 UMAC +36.34% against the close of 02/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Unusual Machines Completes Acquisitions of Fat Shark and Rotor Riot

16:01 ET after hours

48 BMR More than one ranked move this month 2+ ranked moves +35.70% against the close of 02/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

16:15 ET after hours

49 AHG +35.67% against the close of 01/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition AHG Announces Plan to Acquire Online Clinic

16:00 ET after hours

50 PEGA +35.67% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pega Delivers Double-Digit ACV Growth and Record Cash Flow in Q4 2023

16:05 ET after hours

51 FREE +35.33% against the close of 02/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Whole Earth Brands Signs Definitive Agreement to be Acquired by Affiliates of Sababa Holdings FREE, LLC

08:00 ET premarket

52 LYFT +35.12% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lyft Announces Fourth Quarter and Full-Year 2023 Results

16:05 ET after hours

53 DOOR +35.09% against the close of 02/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Owens Corning Announces $3.9 Billion Acquisition of Masonite to Strengthen Position in Building and Construction Materials

07:05 ET premarket

54 LUNR +34.54% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement IM-1 Mission Nova-C Lunar Lander Successfully Enroute to the Moon Following its Launch on SpaceX’s Falcon 9

09:09 ET premarket

55 AREN +34.53% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Manoj Bhargava Invests $12 Million More in The Arena Group

18:25 ET after hours

56 ADVM Also on the opposite board this month release reads negative on both boards +34.51% against the close of 02/02/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Release reads negative, stock rose 34.51% Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

07:45 ET premarket

57 CFLT +34.09% against the close of 02/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Confluent Announces Fourth Quarter and Fiscal Year 2023 Financial Results

16:03 ET after hours

58 PYXS +33.26% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Pyxis Oncology Announces $50 Million Private Placement

08:00 ET premarket

59 ATRA +33.10% against the close of 01/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

18:30 ET after hours

60 PRLD +33.05% against the close of 02/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

16:05 ET after hours

61 SMCI +32.87% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Supermicro Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2029

17:09 ET after hours

62 CLSK +32.86% against the close of 02/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CleanSpark Reports First Quarter FY2024 Financial Results

16:00 ET after hours

63 WGS +32.63% against the close of 02/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

16:26 ET after hours

64 TELL +32.57% against the close of 02/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tellurian Explores Sale of Haynesville Upstream Assets

07:00 ET premarket

65 WATT +32.30% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement WiGL and Energous Announce Developmental Milestone to Bring Touchless Wireless Power Transfer Networks to Market

09:30 ET intraday

66 VERX release reads negative +32.20% against the close of 02/28/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 32.20% Vertex Announces Fourth Quarter and Full Year 2023 Financial Results

07:00 ET premarket

67 BLNK +32.09% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET

07:45 ET premarket

68 CVNA +32.09% against the close of 02/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Carvana Announces Record Fourth Quarter and Full Year 2023 Results

16:10 ET after hours

69 IOVA +31.48% against the close of 02/16/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution catalyst from a later release the same session Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

17:30 ET after hours

70 MNY +31.43% against the close of 02/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change MoneyHero Group Announces Resignation of Chief Financial Officer

16:30 ET after hours

71 TENX Also on the opposite board this month on both boards +31.31% against the close of 02/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

08:30 ET premarket

72 AHCO +31.06% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook

07:00 ET premarket

73 HIMS +31.02% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

74 OSS +30.82% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement OSS to Present at the 36th Annual ROTH Conference, March 17-19, 2024

08:31 ET premarket

75 PLTR +30.80% against the close of 02/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Palantir Reports Its Fifth Consecutive Quarter of GAAP Profitability; Fourth Quarter GAAP EPS of $0.04

16:05 ET after hours

76 BYND +30.72% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Beyond Meat® Reports Fourth Quarter and Full Year 2023 Financial Results

16:05 ET after hours

77 GOTU +30.64% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

02:00 ET premarket

78 UAVS +30.36% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change AgEagle Aerial Systems Appoints Seasoned Defense Industry Executive William Irby as President

08:00 ET premarket

79 LFST +30.00% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings LifeStance Reports Fourth Quarter and Full Year 2023 Results

06:00 ET premarket

80 CDXS +29.69% against the close of 02/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

16:05 ET after hours

81 BOF More than one ranked move this month 2+ ranked moves +29.56% against the close of 02/23/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BranchOut Food Significantly Expands Relationship with Nation's Largest Warehouse Club with New Orders Adding ~$900,000 in Q3 of 2024

08:00 ET premarket

82 CADL +29.50% against the close of 02/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma

07:30 ET premarket

83 TYRA +29.29% against the close of 02/01/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing

08:00 ET premarket

84 AGTI +29.06% against the close of 02/23/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Agiliti to Be Taken Private by THL Partners

08:00 ET premarket

85 ASPI +29.03% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution ASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap Energy

13:49 ET intraday

86 OCUL +28.99% against the close of 02/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement

07:31 ET premarket

87 CELU +28.45% against the close of 01/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline

09:00 ET premarket

88 FROG +28.44% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings JFrog Announces Fourth Quarter and Fiscal 2023 Results

16:05 ET after hours

89 VTYX release reads negative +28.43% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 28.43% Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress

16:01 ET after hours

90 AGFY +28.10% against the close of 02/28/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Agrify Corporation Announces $3.4 Million Sales Order From New Jersey Woman-Owned Business HarvestWorks Farm

07:30 ET premarket

91 SPIR +28.10% against the close of 02/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Spire Global and Signal Ocean Collaborate to Drive Digitalization of the Maritime Economy; Signal Ocean to Make $10 Million Strategic Investment in Spire Global

16:05 ET after hours

92 CLDX +27.76% against the close of 02/23/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

14:05 ET intraday

93 KULR +27.76% against the close of 02/16/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement KULR Receives Non-Compliance Notice from NYSE American

17:15 ET after hours

94 HCSG +27.17% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings HCSG Reports Q4 2023 Results

07:00 ET premarket

95 CRVO +27.12% against the close of 02/09/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies

08:00 ET premarket

96 HYLN +27.03% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Hyliion Holdings Reports Fourth-Quarter and Full-Year 2023 Financial Results

16:30 ET after hours

97 ELMD +26.92% against the close of 02/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter

16:05 ET after hours

98 COCH +26.75% against the close of 02/02/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley

11:00 ET intraday

99 TGTX +26.74% against the close of 02/27/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

07:00 ET premarket

100 SNCR +26.20% against the close of 02/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Synchronoss Successfully Completes Post-Divestiture Cost Removals, Resulting in Approximately $15 Million in Annual Savings

08:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 742 smaller events this month are held out of this month's eligible pool; switch to include them. 234 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.

3 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In February 2024, the median gainer had given back 5.0% of its move five sessions later; the largest catalyst group was Earnings, 32 of the 100 events, at a median of +33.0%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Earnings 32 32.0% +33.0% +38.8% 100.0% of 32
Other Announcement 23 23.0% +34.5% +25.9% 87.0% of 23
Offering / Dilution 14 14.0% +35.1% +34.4% 92.9% of 14
M&A / Acquisition 10 10.0% +36.0% +41.1% 90.0% of 10
Clinical Trial Results 10 10.0% +89.9% +54.6% 100.0% of 10

4 other catalyst types, 11 events: Contract / Partnership, Leadership Change, FDA & Regulatory, Uplisting / Compliance.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 100.0% of 100 0.3% further above baseline, of 100
Day +5 93.0% of 100 5.0% given back, of 100
Month end 93.7% of 95 2.0% given back, of 95
Month end falls before day +5 for 28 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside February 2024

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
BMR 3Other Announcement, Offering / Dilution +371.56%
MNPR 2Clinical Trial Results +96.49%
BOF 2Other Announcement +80.06%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
CNXA 2024-01, 2023-12 +101.21%
SIDU 2024-01, 2023-12 +163.16%
ABVC 2024-01, 2023-11 +60.83%
GNS 2024-01, 2023-12 +28.77%
AXGN 2024-01, 2023-11 +36.90%
LAES 2024-01, 2023-12 +21.87%
HRTX 2024-01, 2023-11 +59.26%
XOS 2024-01, 2023-11 +30.90%
SBGI 2024-01, 2023-11 +34.31%
SLDB 2023-12, 2023-11 +68.42%
PRCH 2023-12, 2023-11 +34.35%
CVRX 2023-12, 2023-11 +29.30%
LASEthis month too 2023-12, 2023-11 +30.32%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market58.0%
  • Intraday4.0%
  • After hours38.0%

Volume against normal

  • Under 5x16 events, 16.3%
  • 5x to 20x42 events, 42.9%
  • Over 20x40 events, 40.8%

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations23 events, 23.0%
  • Biological Products, (no Diagnostic Substances)8 events, 8.0%
  • Services-prepackaged Software6 events, 6.0%
  • Food and Kindred Products3 events, 3.0%
  • Communications Services, Nec2 events, 2.0%
  • Electromedical & Electrotherapeutic Apparatus2 events, 2.0%

37 other industries, 42 events

Industry not known: 14.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against January 2024

100 events in the comparable window.

January 2024 median +26.7%, selected from the 5,543 events in that month's eligible pool

February 2024 median +35.5%, 8.8 points above January 2024. February 2024's median is taken over the 100 ranked rows, selected from the 7,282 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.